Short-Course Ciproflox Treatment of Acute Uncomplicated Urinary Tract Infection in Women: The Minimum Effective Dose

Archives of Internal Medicine

Volumn 155, Issue 5, 1995, Pages 485-494

  Iravani, Abdollah ^a   Tice, Alan D ^b   McCarty, James ^c   Sikes, David H ^d   Nolen, Thomas ^e   Gallis, Harry A ^f   Whalen, Edward P ^g   Tosiello, Robert L ^g   Heyd, Allen ^g   Kowalsky, Steven F ^g   Echols, Roger M ^g  

^a Ctrl Florida Med Res Center   (United States)

^b Infectious Ltd   (United States)

^c California Medical Research Group   (United States)

^d East Pasco Specialty Care ^*  (United States)

^e Columbiana ^*  (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NORFLOXACIN; PLACEBO;

ADULT; AGED; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT FAILURE; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; ACUTE DISEASE; ADOLESCENT; DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; RECURRENT DISEASE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 0028909402     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430050061007     Document Type: Article

References (28)

1. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
2. Rubin RH, Beam TR Jr, Stamm WE. An approach to evaluating antibacterial agents in the treatment of urinary tract infection. Clin Infect Dis. 1992;14 (suppl 2):S249-S251.
3. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990;12:458-467.
4. Iravani A. Advances in the understanding and treatment of urinary tract infections in young women. Urology. 1991;37:503-511.
5. Andriole VT. Use of quinolones in treatment of prostatitis and lower urinary tract infections. Eur J Clin Microbiol Infect Dis. 1991:10:342-350.
6. Hooton TM, Latham RH, Wong ES, Johnson C, Roberts PL, Stamm WE. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother. 1989;33:1308-1312.
7. Basista MP. Randomized study to evaluate efficacy and safety of ofloxacin vs trimethoprim and sulfamethoxazole in treatment of uncomplicated urinary tract infection. Urology. 1991;37(suppl 3):21-27.
8. Hooton TM, Johnson C, Winter C, et al. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother. 1991;35:1479-1483.
9. Craft JC, Hurley M, Hsu P, Pernet A. Efficacy and safety of three-day temafloxacin versus seven day ciprofloxacin therapy in the treatment of uncomplicated urinary tract infections. Eur J Clin Microbiol Infect Dis. 1991;(special issue):195-196.
10. Iravani A. Treatment of uncomplicated urinary tract infections with temafloxacin. Am J Med. 1991;91(suppl 6A):124S-128S.
11. Stein GE, Philip E. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women. J Fam Pract. 1992;34: 180-184.
12. Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med. 1993;94(suppl 3A):89S-96S.
13. Backhouse CI, Matthews JA. Single-dose enoxacin compared with 3-day treatment for urinary tract infection. Antimicrob Agents Chemother. 1989;33:877-880.
14. Iravani A. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults. Am J Med. 1992;92(suppl 4A):75S-81S.
15. Saginur R, Nicolle LE, Canadian Clinical Trials Study Group. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Arch Intern Med. 1992;152:1233-1237.
16. Nicolle LE, DuBois J, Martel Y, et al. Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother. 1993:37:574-579.
17. Garlando F, Rietiker S, Tauber MG, Flepp M, Meier B, Luthy R. Singledose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother. 1987;31:354-356.
18. Raz R, Rottensterich E, Hefter H, Kennes Y, Potasman I. Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women. Eur J Clin Microbiol Infect Dis. 1989;8:1040-1042.
19. Fischbach F, Loos W, Hugo RV, Machka K. Graeff H. Ciprofloxacin in the treatment of patients with symptomatic and asymptomatic urinary tract infections: a comparative study of single-dose application versus three-day treatment concerning efficacy and safety. In: Proceedings of the 14th International Congress of Chemotherapy: Recent Advances in Chemotherapy, Section 2. Tokyo, Japan: University of Tokyo Press; 1985:197.
20. Gellerman HJ, Grote J. Peters-Haertel W, Verbeek H. Short-course treatment with ciprofloxacin of uncomplicated infections of the female urinary tract. Med World. 1988;39:1586-1591.
21. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1984. M2-A3.
22. Koch G, Carr G, Amara I, et al. Categorical data analysis. In: Berry DA, ed. Statistical Methodology in the Pharmaceutical Sciences. New York, NY: Marcel Dekker Inc; 1990:chap 13.
23. Makuch R, Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep. 1978;62:1037-1040.
24. Blackwelder WC. Proving the null hypothesis in clinical trials. Controlled Clin Trials. 1982;3:345-353.
25. Rodary C, Com-Nougue C, Tournade M. How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology. Stat Med. 1989;8:593-598.
26. Harkins RD, Albrecht R. Design and analysis of clinical trials for anti-infective drug products. Drug Info J. 1990;24:213-224.
27. Fihn SD, Latham RH, Roberts P, Running K, Stamm WE. Association between diaphragm use and urinary tract infection. JAMA. 1985;254:240-245.
28. Remis RS, Gurwith MJ, Gurwith D, Hargrett-Bean NT, Layde PM. Risk factors for urinary tract infection. Am J Epidemiol. 1987;126:685-694.